References

• 1. Prince M, Guerchet M, Prina M. The epidemiology and impact of dementia current state and future trends. WHO Thematic Briefing 2015. Available https://hal.science/hal-03517019v1/preview/WHO-%20Demen-tia_thematicbrief_epidemiology_2015.pdf Accessed: 26 Ocak 2023. google scholar
• 2. Işık AT, Tanrıdağ O, Geriatri Pratiğinde Demans Sendromu, SomKitap, İstanbul, 2009. google scholar
• 3. Pereira AA, Weiner DE, Scott T, Sarnak MJ. Cognitive function in dialysis patients. American journal of kid-ney diseases : the official journal of the National Kidney Foundation. 2005;45(3):448-62. Epub 2005/03/09. doi: 10.1053/j.ajkd.2004.10.024. PubMed PMID: 15754267. google scholar
• 4. Salisbury D, Bronas U. Reactive oxygen and nitrogen species: impact on endothelial dysfunction. Nur-sing research. 2015;64(1):53-66. Epub 2014/12/17. doi: 10.1097/nnr.0000000000000068. PubMed PMID: 25502061. google scholar
• 5. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, et al. Association between albumi-nuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012;7(12):1938-46. Epub 2012/10/02. doi: 10.2215/cjn.03500412. PubMed PMID: 23024164; PubMed Central PMCID: PMCPMC3513744. google scholar
• 6. Lisowska-Myjak B. Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract. 2014;128(3-4):303-11. Epub 2014/12/23. doi: 10.1159/000369817. PubMed PMID: 25531673. google scholar
• 7. Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR. Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer disease and associated disorders. 2002;16(3):187-90. Epub 2002/09/10. doi: 10.1097/00002093-200207000-00009. PubMed PMID: 12218650. google scholar
• 8. Kobayashi M, Hirawa N, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S, et al. Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant. 2009;24(1):201-7. Epub 2008/08/14. doi: 10.1093/ndt/gfn419. PubMed PMID: 18697797; PubMed Central PMCID: PMCPMC2639313. google scholar
• 9. Chang CY, Lin CC, Tsai CF, Yang WC, Wang SJ, Lin FH, et al. Cognitive impairment and hippocampal atrophy in chronic kidney disease. Acta Neurol Scand. 2017;136(5):477-85. Epub 2017/03/07. doi: 10.1111/ ane.12753. PubMed PMID: 28261781. google scholar
• 10. Yoshimitsu T, Hirakata H, Fujii K, Kanai H, Hirakata E, Higashi H, et al. Cerebral ischemia as a causa-tive mechanism for rapid progression of brain atrophy in chronic hemodialysis patients. Clin Nephrol. 2000;53(6):445-51. Epub 2000/07/06. PubMed PMID: 10879664. google scholar
• 11. Tsuruya K, Yoshida H, Kuroki Y, Nagata M, Mizumasa T, Mitsuiki K, et al. Brain atrophy in peritoneal dialysis and CKD stages 3-5: a cross-sectional and longitudinal study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2015;65(2):312-21. Epub 2014/09/15. doi: 10.1053/j. ajkd.2014.07.011. PubMed PMID: 25218680. google scholar
• 12. Takae K, Hata J, Ohara T, Yoshida D, Shibata M, Mukai N, et al. Albuminuria Increases the Risks for Both Alzheimer Disease and Vascular Dementia in Community-Dwelling Japanese Elderly: The Hisayama Study. J Am Heart Assoc. 2018;7(2). Epub 2018/01/22. doi: 10.1161/jaha.117.006693. PubMed PMID: 29353232; PubMed Central PMCID: PMCPMC5850144. google scholar
• 13. Berger I, Wu S, Masson P, Kelly PJ, Duthie FA, Whiteley W, et al. Cognition in chronic kidney disease: a systematic review and meta-analysis. BMC medicine. 2016;14(1):206. Epub 2016/12/15. doi: 10.1186/ s12916-016-0745-9. PubMed PMID: 27964726; PubMed Central PMCID: PMCPMC5155375. google scholar
• 14. Iyasere O, Okai D, Brown E. Cognitive function and advanced kidney disease: longitudinal trends and impact on decision-making. Clin Kidney J. 2017;10(1):89-94. Epub 2017/06/24. doi: 10.1093/ckj/sfw128. PubMed PMID: 28638609; PubMed Central PMCID: PMCPMC5469575. google scholar
• 15. Miyazawa H, Ookawara S, Ito K, Ueda Y, Yanai K, Ishii H, et al. Association of cerebral oxygenation with estimated glomerular filtration rate and cognitive function in chronic kidney disease patients without dialysis therapy. PloS one. 2018;13(6):e0199366. Epub 2018/06/26. doi: 10.1371/journal.pone.0199366. PubMed PMID: 29940017; PubMed Central PMCID: PMCPMC6016918. google scholar
• 16. Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various defini-tions of intradialytic hypotension. J Am Soc Nephrol. 2015;26(3):724-34. Epub 2014/10/02. doi: 10.1681/ asn.2014020222. PubMed PMID: 25270068; PubMed Central PMCID: PMCPMC4341481. google scholar
• 17. Chesterton LJ, Selby NM, Burton JO, Fialova J, Chan C, McIntyre CW. Categorization of the hemodynamic response to hemodialysis: the importance of baroreflex sensitivity. Hemodial Int. 2010;14(1):18-28. Epub 2009/11/06. doi: 10.1111/j.1542-4758.2009.00403.x. PubMed PMID: 19888950. google scholar
• 18. Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant. 2005;20(6):1140-7. Epub 2005/04/14. doi: 10.1093/ndt/gfh808. PubMed PMID: 15827047. google scholar
• 19. Joshee P, Wood AG, Wood ER, Grunfeld EA. Meta-analysis of cognitive functioning in patients following kidney transplantation. Nephrol Dial Transplant. 2018;33(7):1268-77. Epub 2017/10/11. doi: 10.1093/ndt/ gfx240. PubMed PMID: 28992229; PubMed Central PMCID: PMCPMC6031036. google scholar
• 20. McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 2009;33(3):355-66. Epub 2008/11/11. doi: 10.1016/j.neubiorev.2008.10.005. PubMed PMID: 18996146. google scholar
• 21. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifi-able risk factors for cognitive decline and dementia: A population-based perspective. Alzheimer’s & de-mentia : the journal of the Alzheimer’s Association. 2015;11(6):718-26. Epub 2015/06/06. doi: 10.1016/j. jalz.2015.05.016. PubMed PMID: 26045020. google scholar
• 22. Farragher JF, Stewart KE, Harrison TG, Engel L, Seaton SE, Hemmelgarn BR. Cognitive interventi-ons for adults with chronic kidney disease: protocol for a scoping review. Syst Rev. 2020;9(1):58. Epub 2020/03/19. doi: 10.1186/s13643-020-01320-x. PubMed PMID: 32183894; PubMed Central PMCID: PM-CPMC7076949. google scholar
• 23. The IPA Complete Guides to Behavioural and Psychological Symptoms of Dementia - Specialists Guide 2012. google scholar
• 24. Ates Bulut E, Soysal P, Işık AT, Demans. Soysal P, Işık AT ed. Geriatri Pratiğinde Geriatrik Sendromlar, US Akademi, İzmir, 2018. google scholar
• 25. Best Practice Guideline for Accommodating and Managing Behaviouraland Psychological Symptoms of Dementia in Residential Care. A Person-Centered Interdisciplinary Approach. British Colombia. October 25, 2012) https://www.health.gov.bc.ca/library/publications/year/2012/bpsd-guideline.pdf google scholar
• 26. Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1997;30(1):41-9. Epub 1997/07/01. doi: 10.1016/s0272-6386(97)90563-1. PubMed PMID: 9214400. google scholar
• 27. Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age and ageing. 2006;35(4):350-64. Epub 2006/05/02. doi: 10.1093/ageing/afl005. Pub-Med PMID: 16648149. google scholar
• 28. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-22. Epub 2013/09/03. doi: 10.1016/s0140-6736(13)60688-1. PubMed PMID: 23992774; PubMed Central PM-CID: PMCPMC4120864. google scholar
• 29. Yasui-Furukori N, Tarakita N, Uematsu W, Saito H, Nakamura K, Ohyama C, et al. Delirium in hemodialysis predicts mortality: a single-center, long-term observational study. Neuropsychiatric disease and treatment. 2017;13:3011-6. Epub 2017/12/26. doi: 10.2147/ndt.S152355. PubMed PMID: 29276387; PubMed Central PMCID: PMCPMC5733909. google scholar
• 30. Inouye SK. Delirium in older persons. The New England journal of medicine. 2006;354(11):1157-65. Epub 2006/03/17. doi: 10.1056/NEJMra052321. PubMed PMID: 16540616. google scholar
• 31. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Annals of internal medicine. 1990;113(12):941-8. Epub 1990/12/15. PubMed PMID: 2240918. google scholar
• 32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washin-gton, DC,2013. google scholar
• 33. Ateş Bulut E, Işık AT. Deliryum. Işık AT, Soysal P, editörler. Geriatrik Aciller. 1. Baskı. Ankara: Türkiye Klinikleri; 2019. p.16-21. google scholar
• 34. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Annals of internal medicine. 1993;119(6):474-81. Epub 1993/09/15. PubMed PMID: 8357112. google scholar
• 35. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. Jama. 1996;275(11):852-7. Epub 1996/03/20. Pub-Med PMID: 8596223. google scholar
• 36. Mercadante S, Arcuri E. Opioids and renal function. J Pain. 2004;5(1):2-19. Epub 2004/02/21. doi: 10.1016/j.jpain.2003.09.007. PubMed PMID: 14975374. google scholar
• 37. Hung TY, Seow VK, Chong CF, Wang TL, Chen CC. Gabapentin toxicity: an important cause of altered consciousness in patients with uraemia. Emerg Med J. 2008;25(3):178-9. Epub 2008/02/27. doi: 10.1136/ emj.2007.053470. PubMed PMID: 18299377. google scholar
• 38. Laskin OL, Longstreth JA, Whelton A, Rocco L, Lietman PS, Krasny HC, et al. Acyclovir kinetics in end-stage renal disease. Clinical pharmacology and therapeutics. 1982;31(5):594-601. Epub 1982/05/01. doi: 10.1038/clpt.1982.83. PubMed PMID: 7075109. google scholar
• 39. Hshieh TT, Inouye SK, Oh ES. Delirium in the Elderly. The Psychiatric clinics of North America. 2018;41(1):1-17. Epub 2018/02/08. doi: 10.1016/j.psc.2017.10.001. PubMed PMID: 29412839. google scholar
• 40. Kalish VB, Gillham JE, Unwin BK. Delirium in older persons: evaluation and management. American family physician. 2014;90(3):150-8. Epub 2014/08/01. PubMed PMID: 25077720. google scholar
• 41. Inouye SK, Bogardus ST, Jr., Charpentier PA, Leo-Summers L, Acampora D, Holford TR, et al. A multicom-ponent intervention to prevent delirium in hospitalized older patients. The New England journal of medicine. 1999;340(9):669-76. Epub 1999/03/04. doi: 10.1056/nejm199903043400901. PubMed PMID: 10053175. google scholar
• 42. Hoffmann M, Schneider D. Practice guidelines for the treatment of patients with delirium. Skolnik NS, editor. Current clinical practice: essential practice guidelines in primary care. Totowa: Humana Press; 2007. google scholar
• 43. Sadlonova M, Duque L, Smith D, Madva EN, Amonoo HL, Vogelsang J, et al. Pharmacologic treatment of delirium symptoms: A systematic review. General hospital psychiatry. 2022;79:60-75. Epub 2022/11/15. doi: 10.1016/j.genhosppsych.2022.10.010. PubMed PMID: 36375344. google scholar
• 44. Esra Ates Bulut, A Turan ISIK: Approach to the Elderly Patient with Delirium: Geriatrician’s Perspective. Eds: A Turan ISIK, George T. GROSSBERG: Delirium in Elderly Patients, Springer, 2018 (ISBN:978-3-319-65237-5) e ISBN: 978-3-319-65239-9 google scholar
• 45. Sultan SS. Assessment of role of perioperative melatonin in prevention and treatment of postoperative deliri-um after hip arthroplasty under spinal anesthesia in the elderly. Saudi journal of anaesthesia. 2010;4(3):169-73. Epub 2010/12/31. doi: 10.4103/1658-354x.71132. PubMed PMID: 21189854; PubMed Central PMCID: PMCPMC2980663. google scholar
• 46. Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin SM, Esbaugh J, Dasgupta M. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. International journal of geriatric psyc-hiatry. 2011;26(7):687-94. Epub 2010/09/17. doi: 10.1002/gps.2582. PubMed PMID: 20845391. google scholar
• 47. McQuillan R, Jassal SV. Neuropsychiatric complications of chronic kidney disease. Nat Rev Nephrol. 2010;6(8):471-9. Epub 2010/06/23. doi: 10.1038/nrneph.2010.83. PubMed PMID: 20567247. google scholar
• 48. Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49(2):124-38. Epub 2004/04/07. doi: 10.1177/070674370404900208. PubMed PMID: 15065747. google scholar
• 49. Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84(1):179-91. Epub 2013/03/15. doi: 10.1038/ki.2013.77. PubMed PMID: 23486521. google scholar
• 50. Jia F, Li X, Liu F, Shi X, Liu H, Cao F. Association of renal function and depressive symptoms: Evi-dence from the China health and retirement longitudinal study. Journal of psychosomatic research. 2020;137:110224. Epub 2020/08/31. doi: 10.1016/j.jpsychores.2020.110224. PubMed PMID: 32862061. google scholar
• 51. Wu L, Yan Z, Jiang H, Xing H, Li H, Qiu C. Serum cystatin C, impaired kidney function, and geriatric depressive symptoms among older people living in a rural area: a population-based study. BMC geriatrics. 2018;18(1):265. Epub 2018/11/08. doi: 10.1186/s12877-018-0957-2. PubMed PMID: 30400830; PubMed Central PMCID: PMCPMC6219054. google scholar
• 52. Flythe JE. ASCENDing to New Heights in Our Understanding of the Treatment of Depression Among Individuals Receiving Hemodialysis. Annals of internal medicine. 2019;170(6):414-5. Epub 2019/02/26. doi: 10.7326/m19-0526. PubMed PMID: 30802907; PubMed Central PMCID: PMCPMC7228203. google scholar
• 53. O’Connor E, Rossom RC, Henninger M, Groom HC, Burda BU, Henderson JT, et al. U.S. Preventive Ser-vices Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Screening for Depression in Adults: An Updated Systematic Evidence Review for the US Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016. google scholar
• 54. Zunszain PA, Hepgul N, Pariante CM. Inflammation and depression. Curr Top Behav Neurosci. 2013;14:135-51. Epub 2012/05/04. doi: 10.1007/7854_2012_211. PubMed PMID: 22553073. google scholar
• 55. Ahrens T, Deuschle M, Krumm B, van der Pompe G, den Boer JA, Lederbogen F. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psy-chosomatic medicine. 2008;70(4):461-7. Epub 2008/04/02. doi: 10.1097/PSY.0b013e31816b1aaa. PubMed PMID: 18378864. google scholar
• 56. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depres-sion. Trends Immunol. 2006;27(1):24-31. Epub 2005/12/01. doi: 10.1016/j.it.2005.11.006. PubMed PMID: 16316783; PubMed Central PMCID: PMCPMC3392963. google scholar
• 57. Kimmel PL. Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: cor-relates and outcomes. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2000;35(4 Suppl 1):S132-40. Epub 2000/04/15. doi: 10.1016/s0272-6386(00)70240-x. PubMed PMID: 10766011. google scholar
• 58. Koo JR, Yoon JW, Kim SG, Lee YK, Oh KH, Kim GH, et al. Association of depression with malnutrition in chronic hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003;41(5):1037-42. Epub 2003/05/02. doi: 10.1016/s0272-6386(03)00201-4. PubMed PMID: 12722038. google scholar
• 59. Rosenthal Asher D, Ver Halen N, Cukor D. Depression and nonadherence predict mortality in hemodi-alysis treated end-stage renal disease patients. Hemodial Int. 2012;16(3):387-93. Epub 2012/04/04. doi: 10.1111/j.1542-4758.2012.00688.x. PubMed PMID: 22469200; PubMed Central PMCID: PMCP-MC3390437. google scholar
• 60. Halen NV, Cukor D, Constantiner M, Kimmel PL. Depression and mortality in end-stage renal disease. Curr Psychiatry Rep. 2012;14(1):36-44. Epub 2011/11/23. doi: 10.1007/s11920-011-0248-5. PubMed PMID: 22105534. google scholar
• 61. Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by Europe-an Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736-45. Epub 2012/08/04. doi: 10.1093/ndt/gfs295. PubMed PMID: 22859791. google scholar
• 62. Hedayati SS, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 2012;81(3):247-55. Epub 2011/10/21. doi: 10.1038/ki.2011.358. PubMed PMID: 22012131; PubMed Central PMCID: PMCPMC3258342. google scholar
• 63. Cohen LM, Tessier EG, Germain MJ, Levy NB. Update on psychotropic medication use in renal disea-se. Psychosomatics. 2004;45(1):34-48. Epub 2004/01/08. doi: 10.1176/appi.psy.45.1.34. PubMed PMID: 14709759. google scholar
• 64. Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: A review for clinicians. The Australian and New Zealand journal of psychiatry. 2014;48(6):530-41. Epub 2014/03/25. doi: 10.1177/0004867414528589. PubMed PMID: 24658294. google scholar